rpia Search Results


93
Proteintech pri mary antibodies
Pri Mary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/RPIA+Antibody/pm35651290-177-17-24
Average 93 stars, based on 1 article reviews
pri mary antibodies - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti rpia
Mouse Monoclonal Anti Rpia, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/RPIA+Antibody/pmc12166406-27-0-4
Average 93 stars, based on 1 article reviews
mouse monoclonal anti rpia - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

85
Thermo Fisher gene exp rpia mm00485790 m1
Gene Exp Rpia Mm00485790 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/Gene+Exp%2E+Rpia%2C+Mm00485790_m1/pmc04295165-74-24-0
Average 85 stars, based on 1 article reviews
gene exp rpia mm00485790 m1 - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

91
Aviva Systems escherichia coli
Escherichia Coli, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/Recombinant+Escherichia+coli+Ribose-5-phosphate+isomerase+A(rpiA)/pm35909349-65-6-9
Average 91 stars, based on 1 article reviews
escherichia coli - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
Moravek Biochemicals 3 h]pa
3 H]Pa, supplied by Moravek Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/3h+r+pia/pmc02891058-71-2-10
Average 90 stars, based on 1 article reviews
3 h]pa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Moravek Biochemicals 3h]r—n6-(2-phenylisopropyl)adenosine 42.6 ci/mmol
3h]R—N6 (2 Phenylisopropyl)adenosine 42.6 Ci/Mmol, supplied by Moravek Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/3+h+labeled+r++phenylisopropyladenosine++++3+h+r+pia++30+5+ci+mmol+/us09227979-159-3-7
Average 90 stars, based on 1 article reviews
3h]r—n6-(2-phenylisopropyl)adenosine 42.6 ci/mmol - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bioneer Corporation rpia-s302a-f atgcaggatggcgcagtgaacatgagg
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
Rpia S302a F Atgcaggatggcgcagtgaacatgagg, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/rpia+s302a+f+atgcaggatggcgcagtgaacatgagg/pmc11217295-167-25-37
Average 90 stars, based on 1 article reviews
rpia-s302a-f atgcaggatggcgcagtgaacatgagg - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Boehringer Ingelheim n 6 -( r )-phenyliso-propyl-adenosine, r-pia
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
N 6 ( R ) Phenyliso Propyl Adenosine, R Pia, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/n+6++++r+++phenyliso+propyl+adenosine++r+pia/pmc03561777-59-22-3
Average 90 stars, based on 1 article reviews
n 6 -( r )-phenyliso-propyl-adenosine, r-pia - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Boehringer Mannheim r-pia
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
R Pia, supplied by Boehringer Mannheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/r+pia/pmc03478951-24-0-9
Average 90 stars, based on 1 article reviews
r-pia - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioResource International Inc rpia-1 gene partially deleted knockout strains tm7117
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
Rpia 1 Gene Partially Deleted Knockout Strains Tm7117, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/rpia+1+gene+partially+deleted+knockout+strains+tm7117/pmc09854458-134-15-31
Average 90 stars, based on 1 article reviews
rpia-1 gene partially deleted knockout strains tm7117 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Microm International GmbH r-pia
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
R Pia, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/r+pia/pmc01910329-27-4-6
Average 90 stars, based on 1 article reviews
r-pia - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc 3h]rpia
( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as <t>K173R.</t> ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .
3h]Rpia, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpia/3h+r+pia/10__1016_slash_j__bmc__2010__02__039-252-0-3
Average 90 stars, based on 1 article reviews
3h]rpia - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as K173R. ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .

Journal: The EMBO Journal

Article Title: The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate

doi: 10.1038/s44318-024-00100-w

Figure Lengend Snippet: ( A – F ) Measures of the impact of PKR activity on the major products of the oxidative and nonoxidative phases of the PPP. ( A – C ) Plots of the effect of PKR on the levels of ribose 5-phosphate produced in the nonoxidative phase of the PPP by measures of FAD by ( A ) coupled enzyme assay ( n = 6 independent assays) or ( B ) the molecules fluorescence in WT and Eif2ak2 −/− splenic macrophages ( n = 4) and ( C ) bone marrow-derived macrophages expressing the control (shC) or Eif2ak2 − /− targeting (shP) shRNA as detected by the FACS ( n = 3). ( D , E ) Plots of the effect of PKR on the levels of ribose 5-phosphate by measures of nucleic acids in the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages through staining of ( D ) RNA with SYTO RNASelect ( n = 6) or ( E ) DNA with Hoechst 34580 and detection by FACS ( n = 5). ( F ) Plots of the effect of PKR on the levels of the reduced (NADPH) and oxidized (NADP+) forms of nicotinamide adenine dinucleotide phosphate produced in the oxidative phase of the PPP in the splenic WT and Eif2ak2 −/− and the control (shC) or PKR-ablated (shP) bone marrow-derived macrophages by bioluminescent assay (NADP/NADPH-Glo assay) ( n = 3). ( G , H ) Plots demonstrating the impact of expressing the indicated constructs on the PKR-dependent control of ribose 5-phosphate production by measures of FAD fluorescence in bone marrow-derived macrophages co-expressing a ( G ) non-targeting control (shCONT) or ( H ) Eif2ak2 -targeting (shPKR) shRNA ( n = 3). A catalytically impaired, point mutant RPIA construct is abbreviated as K173R. ( I , J ) Plots of cell counts after culture without the addition of saccharides (C) or supplemented with ( I ) glucose (Glu) ( n = 6) or ( J ) D-sedoheptulose (S, n = 3), d -ribose (R, n = 11), d -xylose (X, n = 6), l -arabinose (A, n = 6) or glycerol (G, n = 4) alone and d -ribose combined with d -xylose (R:X, n = 6). The data show the x̅ ± σ. P values shown were calculated by an unpaired student’s t -test of independent experiments. Figures are derived from Source Data file 2. .

Article Snippet: Amino acid substitutions and truncations were produced by site-directed amplification using the following primers with the complementary reverse sequence; RPIA-δ75-F TGACGCGGGATCCATGTCCAAGGCCGAGGAGGCC, FLAG-RPIA-R TTGCTGAATTCTTATCACTTATCGTCGTCATCCTTGTAATC, RPIA-S147A-F GCAGTATGGCTTGACCCTCGCTGATCTGGATCGACACCCA, RPIA-K173R-F GCTGATCTCAATCTCATCAGGGGTGGCGGAGGCTGC, RPIA-S302A-F ATGCAGGATGGCGCAGTGAACATGAGG, RpiA-S75A-F GATCTCAACGAAGTCGACGCCCTTGGCATCTACGTTGATGG, RpiA-T210A-F GGACGTTGCGCTGATTGGCGCACCTGACGGTGTCAAAACC, TALDO1-S171F-F GCAACATGACGTTACTCTTCTTCTTCGCCCAGGCTGTGG, TKT-D155A-F GTCTATTGCTTGCTGGGAGCCGGGGAGCTGTCAGAGG (Bioneer Pacific).

Techniques: Activity Assay, Produced, Enzymatic Assay, Fluorescence, Derivative Assay, Expressing, Control, shRNA, Staining, Glo Assay, Construct, Mutagenesis